Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.58 |
| ▸ | PPARG | P37231 | 8/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | FBP1 | P09467 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7744949 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL154904 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL423102 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL1602959 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL3149613 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL1274680 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL973729 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL29047 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL7568098 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL9361054 | 1.00 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 877 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4212106-B1 | HANDHELD DEVICE FOR APPLYING A CYANOACRYLATE ADHESIVE COMPOSITION | CUANTUM MEDICAL COSMETICS S L (ES) | 2025-11-12 | — | — | EP | claimed |
| WO-2025119863-A1 | PHOTOCURABLE COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE, N-HEXYLCYANOACRYLATE OR N-OCTYLCYANOACRYLATE | BOSTIK SA (FR) | 2025-06-12 | — | — | WO | claimed |
| EP-4567051-A1 | PHOTOCURABLE COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE, N-HEXYLCYANOACRYLATE OR N-OCTYLCYANOACRYLATE | Bostik SA (FR) | 2025-06-11 | — | — | EP | claimed |
| EP-3960151-B1 | PHOTOCURABLE CYANOACRYLATE COMPOSITION WITH CONTROLLED EXOTHERM | CUANTUM MEDICAL COSMETICS S L (ES) | 2025-04-23 | — | — | EP | claimed |
| US-20230323137-A1 | COMPOSITION FOR SEALING COATED ELECTRIC WIRE, AND COATED ELECTRIC WIRE | TOAGOSEI CO. LTD. (JP) | 2023-10-12 | — | — | US | claimed |
| US-11253477-B2 | Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof | EMPRESA BRASILEIRA DE PESQUISA AGROPECUÁRIA—EMBRAPA (BR) | 2022-02-22 | — | — | US | claimed |
| US-20220025552-A1 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2022-01-27 | — | — | US | claimed |
| EP-3941989-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2022-01-26 | — | — | EP | claimed |
| US-20220002590-A1 | Cyanoacrylate Adhesive Composition | HENKEL AG & CO KGAA (DE) | 2022-01-06 | — | — | US | claimed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | claimed |
| EP-1534202-A1 | OPHTHALMIC DRUG DELIVERY SYSTEM | UNIVERSITY OF FLORIDA (US) | 2005-06-01 | — | — | EP | claimed |
| US-20040241207-A1 | Ophthalmic drug delivery system | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2004-12-02 | — | — | US | claimed |
| US-20040096477-A1 | Ophthalmic drug delivery system | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2004-05-20 | — | — | US | claimed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | claimed |
| WO-2003103549-A1 | OPHTHALMIC DRUG DELIVERY SYSTEM | UNIVERSITY OF FLORIDA (US) | 2003-12-18 | — | — | WO | claimed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | claimed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| US-3940362-A | Cross-linked cyanoacrylate adhesive compositions | JOHNSON & JOHNSON (US) | 1976-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | EP300 488/4885PPARG 382/4885PPARA 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.